(Q51496959)

5 April 2018

title

Low plasma ghrelin concentration is an indicator of the metabolic syndrome. (English)

1 reference

5 April 2018

1 reference

Olavi Ukkola

1

1 reference

5 April 2018

Seppo M Pöykkö

series ordinal

2

1 reference

5 April 2018

Y Antero Kesäniemi

series ordinal

3

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 January 2006

1 reference

5 April 2018

published in

Annals of Medicine

1 reference

5 April 2018

volume

38

1 reference

5 April 2018

issue

4

1 reference

5 April 2018

page(s)

274-279

1 reference

5 April 2018

Banting lecture 1988. Role of insulin resistance in human disease

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Clustering of metabolic abnormalities in obese individuals: the role of genetic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Ghrelin: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Circulating ghrelin levels are decreased in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Circulating ghrelin levels in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Ghrelin suppression in overweight children: a manifestation of insulin resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthy men: the atherosclerosis and insulin resistance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Ghrelin concentrations in healthy children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Insulin resistance in obesity: metabolic mechanisms and measurement methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Central role of the adipocyte in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Hypothalamic origin of the metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Hyperleptinaemia: the missing link in the, metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Ghrelin and the metabolic syndrome in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

A novel pathway to the manifestations of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890600622192

10.1080/07853890600622192

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018